[1]. Akhtar M, Jamshaid M, Zaman M, Mirza AZ. Bilayer tablets: A developing novel drug delivery system. J Drug
Deliv Sci Technol [Internet]. 2020;60:102079.
[2]. Kiran BS, Rao PS, Babu GR, College P, Pradesh A. Bilayer tablets – A
review. 2015;5(3):510–6.
[3]. Soni N, Joshi D, Jain V, Pal P. A Review on Applications of Bilayer
Tablet Technology for Drug Combinations. J Drug Deliv Ther. 2022;12:222–7.
[4]. Mishra P, Sharma P, Malviya R. A review on bi-layer tablets - an
emerging trend. J Drug Deliv Ther. 2014 Jul 15;4.
[5]. Sohail Arshad M, Zafar S, Yousef B, Alyassin Y, Ali R, AlAsiri A, et
al. A review of emerging technologies enabling improved solid oral dosage form
manufacturing and processing. Adv Drug Deliv Rev. 2021;178:113840.
[6]. Salawi A. Pharmaceutical Coating and Its Different Approaches, a
Review. Polymers (Basel). 2022 Aug 15;14(16):3318.
[7]. Sharma D. Formulation development and evaluation of fast
disintegrating tablets of salbutamol sulphate for respiratory disorders. ISRN
Pharm. 2013 Jul 15;2013:674507.
[8]. Blicharski T, Swiader K, Serefko A, Kulczycka-Mamona S,
Kolodziejczyk M, Szopa A. Challenges in technology of bilayer and multi-layer
tablets: a mini-review. Curr Issues Pharm Med Sci. 2019 Dec 26;32.
[9]. Agiba AM, Abul-Ella SS, Abd El-Monem RA. Pharmacotechnical development and optimization of multilayered
tablets: an updated industrial review with emphasis on bilayer tablets. Int J
App Pharm. 2021;13(4):55–64.
[10].
Wu CY, Seville JP. A
comparative study of compaction properties of binary and bilayer tablets.
Powder Technol. 2009;189:285–94.
[11].
van der Merwe J, Steenekamp J,
Steyn D, Hamman J. The Role of Functional Excipients in Solid Oral Dosage Forms
to Overcome Poor Drug Dissolution and Bioavailability. Pharmaceutics. 2020;12(5):393.
[12].
Abdul S, Poddar SS. A flexible
technology for modified release of drugs: multi layered tablets. J Control
Release. 2004;97(3):393–405.
[13].
Laracuente ML, Yu MH, McHugh
KJ. Zero-order drug delivery: State of the art and future prospects. J Control
Release. 2020;327:834–56.
[14].
Fina F, Goyanes A, Rowland M,
Gaisford S, W Basit A. 3D Printing of Tunable Zero-Order Release Printlets.
Polymers (Basel). 2020;12(8):1769.
[15].
Abdul S, Poddar SS. A flexible
technology for modified release of drugs:multi layered tablets. J Control Rel,
2004; 97: 393-405.
[16].
Raza MA, Sharma MK, Nagori K,
Jain P, Ghosh V, Gupta U. Recent trends on polycaprolactone as sustainable
polymer-based drug delivery system in the treatment of cancer: Biomedical
applications and nanomedicine. Int J Pharm. 2024;666:124734.
[17].
Ozeki Y, Ando M, Watanabe Y,
Danjo K. Evaluation of novel one-step dry-coated tablets as a platform for
delayed-release tablets. J Control Rel, 2004; 95: 51-60.
[18].
Abebea A, Akselib I, Sprockela
O, Kottalaa N, Alberto MC. Review of bilayer tablet technology. Int J of Phar,
2014; 461: 549-558.
[19].
Vaithiyalingam SR, Sayeed VA.
Critical factors in manufacturing multilayered tablets – assessing material
attributes, in-process controls, manufacturing process and product performance.
Int J Pharm, 2010; 398: 9-13.
[20].
La Force C, Gentile DA, Skoner
DP. A randomized, double-blind, parallel group, multicenter, placebocontrolled
study of the safety and efficacy of extended release of guaifenesin/pseudo
ephedrine hydrochloride for symptom relief as an adjunctive therapy to
antibiotic treatment of acute respiratory infections. Post Grad Med, 2008; 120:
53-59.
[21].
Shiyani B, Gattani S, Surana S.
Formulation and evaluation of bi-layertablet of metoclopramide hydrochloride
and ibuprofen. AAPS Pharm Sci Tech, 2008; 9: 818-827.
[22].
Nirmal J, Saisivam S, peddanna
C, Muralidharan S, Nagrarajan M. Bilayertablets of atrovastatin calcium and
nicotinic acid: formulation and evaluation. Chem Pharm Bull, 2008; 56:
1455-1458.
[23].
Serebruany VL, Malinin AI, Sane
DC, Jilma B, Takserman A, Atar D, et al. Aggrenox and aspirin in patients after
ischemic stroke: the Aggrenox versus aspirin therapy evaluation trial. Eur J
Pharmacol, 2004; 3: 315-324.
[24].
Niwa M, Hiraishi Y, Iwasaki N,
Terada K. Quantitative analysis of the layer separation risk in bilayer tablets
using terahertz pulsed imaging. Int J Pharm, 2013; 452: 249-256.
[25].
Gopinath
C, Bindu VH, Nischala M. An overview on bilayered tablet technology. J Global
Trends Pharm Sci. 2013;4(2):1077–85.
[26].
Yadav A,
Jain DK. Formulation development and in vitro characterization of bilayer and
floating-bioadhesive tablets of propranolol hydrochloride. Asian J Pharm Life
Sci. 2011;1(1):1–12.
[27].
Kiran
B, Rao PS, Babu GR, Kumari MV. Bilayer
tablets—a review. Int J Pharm Chem Biol Sci. 2015;5(3).
[28].
Panchal
HA, Tiwari AK. A novel approach of bilayer tablet technology: a review. Int Res
J Pharm. 2012;3(5):44–9.
[29].
Nagaraju
R, Kaza R. Formulation and evaluation of bilayer sustained release tablets of
salbutamol and theophylline. Int J Pharm Sci Nanotech. 2009;2(3):638–46.
[30].
Nirmal J,
Saisivam S, Peddanna C, Muralidharan S, Godwinkumar S, Nagarajan M. Bilayer
tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation.
Chem Pharm Bull. 2008;56(10):1455–8.
[31].
Patra C,
Kumar A, Pandit H, Singh S, Devi M. Design and evaluation of sustained release
bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007;57(4):479–89.
[32].
Shiyani B,
Gattani S, Surana S. Formulation and evaluation of bi-layer tablet of
metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech.
2008;9(3):818–27.
[33].
Jin G, Ngo H V, Wang J, Cui
J-H, Cao Q-R, Park C, et al. Design and evaluation of in vivo bioavailability
in beagle dogs of bilayer tablet consisting of immediate release nanosuspension
and sustained release layers of rebamipide. Int J Pharm [Internet]. 2022;619:121718.
[34].
Kumar MK, Narayan S, Singh PK.
A review on advancement of mouth dissolving tablets. Prob. Sci.,
2024;1(1):34-49
[35].
Desai D, Wang J, Wen H, Li X,
Timmins P. Formulation design, challenges, and development considerations for
fixed dose combination (FDC) of oral solid dosage forms. Pharm Dev Technol.
2013;18(6):1265-76.
[36].
Efentakis M, Peponaki C.
Formulation study and evaluation of matrix and three-layer tablet sustained
drug delivery systems based on Carbopols with isosorbite mononitrate. AAPS
Pharm Sci Tech. 2008;9(3):917-23.
[37].
Li SP, Karth MG, Feld KM,
Dipalo LC, Pendaharkar CM, Williams RO. Evaluation of bilayer tablet machines –
a case study. Drug Dev Ind Pharm. 1995;21:571-90.
[38].
Vaithiyalingam SR, Sayeed VA.
Critical factors in manufacturing multilay-ered tablets – assessing material
attributes, in-process controls, manufacturingprocess and product performance.
Int J Pharm. 2010;398:9-13.
[39].
Danckwerts MP. Development of a
zero-order release oral compressed tablet with potential for commercial
tabletting production. Int J Pharm. 1994;112:34-45.
[40].
Hildgen D, McMullen JN. A new
gradient matrix: formulation and characterization. J Control Release.
1995;34:263-71.
[41].
Nirmal J, Saisivam S, Peddanna
C, Muralidharan S, Godwinkumar S, Nagarajan M. Bilayer tablets of atorvastatin
calcium and nicotinic acid: formulation and evaluation. Chem Pharm Bull
(Tokyo). 2008; 56(10):1455-8.
[42].
Shiyani B, Gattani S, Surana S.
Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride
and ibuprofen. AAPS Pharm Sci Tech. 2008;9(3):818-27.
[43].
Rathbone MJ, Hadgraft J,
Roberts MS. Modified-Release Drug Delivery Technology. London: Informa
Healthcare. 2002:59-76.
[44].
Bangalore S, Kamalakkannan G,
Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a
meta-analysis. Am J Med. 2007;120(8):713-19.
[45].
Rathbone MJ, Hadgraft J,
Roberts MS. Modified-Release Drug Delivery Technology. London: Informa
Healthcare. 2002;1-19.
[46].
LaForce C, Gentile DA, Skoner
DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled
study of the safety and efficacy of extended-release
guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive
therapy to antibiotic treatment of acute respiratory infections. Postgrad Med.
2008;120(2):53-9.
[47].
Liu L, Xu X. Preparation of
bilayer-core osmotic pump tablet by coating the indented core tablet. Int J
Pharm. 2008;352(1–2):225–30.
[48].
Siswanto A, Fudholi A, Nugroho
AK, Martono S. In vitro release modeling of aspirin floating tablets using
DDSolver. Indones J Pharm. 2015;26(2):94
[49].
Karudumpala S, Gnanaprakash K,
Venkatesh B, Sankar P, Balaji G, Vidya Sagar N. Formulation and evaluation of
gastro-retentive floating bilayer tablets of nifedipine.
[50].
Yadav A, Jain DK. Formulation
development and in vitro characterization of bilayer and floatingbioadhesive
tablets of propranolol hydrochloride. Asian J Pharm Life Sci, 2011; 1 (1):
1-12.
[51].
Ijaz H, Qureshi J, Danish Z,
Zaman M, Abdel-Daim M, Bashir I. Design and evaluation of bilayer matrix tablet
of metoprolol tartrate and lisinopril maleate. Adv Polym Technol, 2017; 36
(2):152-159.
[52].
Florence AT, Siepmann J. Modern pharmaceutics.
In: Applications and Advances. Vol. 2. Boca Raton: CRC Press; 2016.
[53].
Shirwaikar A, Kumar S, Jacob S,
Rashi W, Ravi K. Recent developments in floating drug delivery systems for
gastric retention of drugs: an overview. Indian Drugs. 2006;43(9):697–704
[54].
Sudhir Dhote N, Dineshbhai
Patel R, Kuwar U, Agrawal M, Alexander A, Jain P, et al. Application of
Thermoresponsive Smart Polymers based in situ Gel as a Novel Carrier for Tumor
Targeting [Internet]. Vol. 24, Current Cancer Drug Targets. 2024. p. 1–22.
[55].
Gohel M, Parikh R, Nagori S,
Jethwa B. Fabrication and evaluation of bilayer tablet containing conventional
paracetamol and modified release diclofenac sodium. Indian J Pharm Sci, 2010;
72 (2): 191-196.
[56].
Rajendran N, Natarajan R,
Subhashini R, Patel H. Formulation and evaluation of sustained release bilayer
tablets of metformin HCl and pioglitazone HCl. Int J Curr Pharm Res, 2011; 3
(3): 118-122.
[57].
Saif
AA, Alburyhi MM, Noman MA, Almaktari AM. Formulation
and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate
multi-unit solid dosage forms. J Chem Pharmaceut Res, 2014; 6(2): 421-426.
[58].
Hiremath D, Goudanavar P,
Azharuddin M, Udupi R, Sarfaraz M. Design and characterization of bilayer
controlled release matrix tablets of losartan potassium. Int J Pharmacol Res,
2010; 2(4): 34-39.
[59].
Deshpande RD, Gowda DV,
Mahammed N, Maramwar DN. Bi-Layer Tablets - An Emerging Trend: A Review. Int J
Pharm Sci Res, 2011; 2(10): 2534-2544.
[60].
Bagyalakshmi J, Krishna YP,
Ravi TK. Bilayer tablet formulation of metformin hydrochloride and glipizide: A
novel approach in the treatment of diabetes, Int J Pham Sci Rev Res; 2011;
8(2): 209- 215.
[61].
Dey S, Chattopadhyay S,
Mazumder B. Formulation and evaluation of fixed-dose combination of bilayer
gastroretentive matrix tablet containing atorvastatin as fast-release and
atenolol as sustained-release. Bio Med Res Int, 2014; 2014: 396106.
[62].
Jain J, Marya B, Mittal R,
Patel M. Formulation and evaluation of indomethacin bilayer sustained release
tablets. Int J Pharm Tech Res, 2011; 3 (2): 1132- 1138.
[63].
Kulkarni A, Bhatia M.
Development and Evaluation of Regioselective Bilayer Floating Tablets of
Atenolol and Lovastatin for Biphasic Release Profile. Ira J Pharm Sci, 2009; 8
(1): 15-25.
[64].
Gaur PK, Mishra S, Prabhakaran
P, Bhardwaj S, Puri D, Kumar SS, et al. Prospectives and potentials of bilayer
technology: a novel approach. Int Pharm Sci Pharmacol. 2015;2(2):148–61.
[65].
Goole J, Amighi K. 3D printing
in pharmaceutics: a new tool for designing customized drug delivery systems.
Int J Pharm. 2016;499(1–2):376–94.
[66].
Indian Pharmacopoeia. New
Delhi: Controller of Publications; 1996. p.764.
[67].
Rameshwar V, Kishor D, Tushar
G. Bi-layer tablets for various drugs: a review. Scholars Acad J Pharm.
2014;3(3):271–9.
[68].
Conley R, Gupta SK, Sathyan G.
Clinical spectrum of the osmotic-controlled release oral delivery system
(OROS), an advanced oral delivery form. Curr Med Res Opin. 2006;22(10):1879–92.
[69].
Lende LKLK, Banerjee S, Gadhave
M, Gaikwad D, Gaykar A. Review on: bilayer floating tablet. Asian J Pharm Res
Dev. 2013;:31–9.
[70].
Ijaz H, Qureshi J, Danish Z,
Zaman M, Abdel-Daim M, Bashir I. Design and evaluation of bilayer matrix tablet
of metoprolol tartrate and lisinopril maleate. Adv Polym Technol.
2017;36(2):152–9.
[71].
Kamila MM, Mondal N, Ghosh LK,
Gupta BK. Multiunit floating drug delivery system of rosiglitazone maleate:
development, characterization, statistical optimization of drug release and in
vivo evaluation. AAPS PharmSciTech. 2009;10(3):887.
[72].
Rekhi GS. Advances in solid
dose oral drug delivery. ON Drug Delivery: Oral Drug Delivery and Advanced
Excipients. 2010;:14–8.
[73].
Chien Y. Novel drug delivery
systems. Boca Raton: CRC Press; 1991.
[74].
Hu L, Hu Q, Kong D. Formulation
and in vitro evaluation of aspirin and isosorbide 5-mono-nitrate sustained
bilayer tablets. Int J Pharm Sci Res. 2014;5(3):799.
[75].
Melocchi A, Parietti F, Loreti
G, Maroni A, Gazzaniga A, Zema L. 3D printing by fused deposition modeling
(FDM) of a swellable/erodible capsular device for oral pulsatile release of
drugs. J Drug Deliv Sci Technol. 2015;30:360–7.
[76].
Singh S. Bilayer tablet
technology: an overview. J Appl Pharm Sci. 2011;1:43–7.
[77].
Sarma A, Deb P, Dash S. Bilayer
tablet and duredas technology–a review. Indian J Pharm Sci. 2013;3(2):554–63.
[78].
Rayakwar N, Dangi YS.
Development and characterization of controlled release bilayered tablets of
Citicoline sodium. J Drug Deliv Ther. 2019;9(2-s):125–31.
[79].
Kumar V, Prasad G, Ganesh B,
Swathi C, Rashmi A, Reddy A. Development and evaluation of guaifenesin bilayer
tablet. Int J Pharm Sci Nanotech. 2010;3(3):1122–8.
[80].
Yeole P, Khan S, Patel V.
Floating drug delivery systems: need and development. Indian J Pharm Sci.
2005;67(3):265.
[81].
Busignies V, Mazel V, Diarra H,
Tchoreloff P. Role of the elasticity of pharmaceutical materials on the
interfacial mechanical strength of bilayer tablets. Int J Pharm.
2013;457(1):260–7.
[82].
Kottala N, Abebe A, Sprockel O,
Bergum J, Nikfar F, Cuitino AM. Evaluation of the performance characteristics
of bilayer tablets: Part I. Impact of material properties and process
parameters on the strength of bilayer tablets. AAPS PharmSciTech. 2012;13(4):1236–42.
[83].
Kottala N, Abebe A, Sprockel O,
Akseli I, Nikfar F, Cuitino AM. Influence of compaction properties and
interfacial topography on the performance of bilayer tablets. Int J Pharm.
2012;436(1–2):171–8.
[84].
Muzzio FJ, Ierapetritou M,
Portillo P, Llusa M, Levin M, Morris KR, et al. A forward-looking approach to
process scale-up for solid dose manufacturing. In: Pharmaceutical Dosage
Forms–Tablets. Boca Raton: CRC Press; 2008. p.135–68.
[85].
Sheetz MP, Painter RG, Singer
S. Biological membranes as bilayer couples. III. Compensatory shape changes
induced in membranes. J Cell Biol. 1976;70(1):193–203.
[86].
Charman SA, Charman WN. Oral
modified-release delivery systems. In: Rathbone MJ, Hadgraft, J, Roberts MS,
editors. Modified-Release Drug Delivery Technology. London: Informa Healthcare;
2002. pp. 1-19.
[87].
Akseli I, Abebe A, Sprockel O,
Cuitino A. Mechanistic characterization of bilayer tablets. Powder Technol,
2013; 236: 30-36.
[88].
Kottala N, Abebe A, Sprockel O,
Bergum J, Nikfar F, Cuitino A. Evaluation of the performance characteristics of
bilayer tablets: Part I. Impact of material properties and process parameters
on the strength of bilayer tablets. AAPS Pharm Sci Tech, 2012a; 13: 1236-1242.
[89].
Kottala N, Abebe A, Sprockel O,
Nikfar F, Cuitino A. Influence of compaction properties and interfacial
topography on the performance of bilayer tablets. Int J Pharm, 2012b; 436:
171-178.
[90].
Martin K, Abebe A, Raghavan K,
Stamato H, Timmins P. Bilayer tablets: effects of upper punch penetration on
the potency of the second layer. Chicago, IL: AAPS Annual Conference; 2012.
[91].
Eiliazadeh B, Briscose B, Sheng
Y. Investigating density distributions for tablets of different geometry during
the compaction of pharmaceuticals. Part Sci Technol, 2003; 21: 303-316.
[92].
Eiliazadeh B, Pitt K, Briscose
B. Effects of punch geometry on powder movement during pharmaceutical
tabletting. Int J Solids Struct, 2004; 41: 5967-5977.
[93].
Podczeck F, Al-Muti E. The
tensile strength of bilayered tablets made from different grades of
microcrystalline cellulose. Eur J Pharm. Sci, 2010; 41: 483-488.
[94].
Klinzing G, Zavaliangos A.
Understanding the effect of environmental history on bilayer tablet interfacial
shear strength. Pharm Res, 2013; 30(5): 1300-1310.
[95].
Zacour B, Pandey P, Subramanian
G, Gao Z, Nikfar F. Correlating bilayer tablet delamination tendencies to
micro-environmental thermodynamic conditions during pan coating. Drug Dev Ind
Pharm, 2014; 40(6): 829-837.
[96].
Akhtar
M, Jamshaid M, Zaman M, Mirza AZ. Bilayer tablets: A
developing novel drug delivery system. J Drug Del Tech, 2020; 60:102079.
[97].
India. Pharmacopoeia of India.
8th ed. Delhi: Controller of Publications; 2018.
[98].
Pujari N, Gupta D. Bilayer
Tablet Technology: A Concept Of Immediate And Controlled Drug Delivery. 2023
Jan 17;14:503–12.
[99].
Arya G, Mamgain S, Abstract A.
Formulation And Evaluation Of Bilayer Tablets For The Treatment Of Diabetes.
Educ Adm Theory Pract. 2024 May 31;30.
[100].
Momin MM, Kane S, Abhang P.
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine
hydrochloride. Front Pharmacol. 2015 Jul 9;6:144.
[101].
Singh A, Das S, Gupta S, Ghosh
S. The Challenges of Producing Bilayer Tablet: A Review. J Drug Deliv Ther.
2021 Aug 15;11:171–5.